Suche
Mein Konto
Bruker Announces Agreement to Acquire Neurescence Inc. to Strengthen Neuroscience Research Portfolio
Bruker Corporation today announced that it has signed a definitive agreement to acquire 100% ownership of Neurescence Inc., an innovative provider of ultralight fiber bundle Multiscopes™ for simultaneous optical functional neuroimaging in multiple regions. Chromatone™, Neurescence's flagship product, removes lighting and detection hardware from the animal's head. This enables simultaneous imaging and stimulation of three subtypes of neurons in up to four regions for flexible study of the central nervous system at single-neuron resolution in naturalistic behavior. This platform creates strong synergies with Bruker's existing Ultima multiphoton solutions and the newly acquired Inscopix head-mounted miniscopes. Financial details of the agreement were not disclosed. Our …
Bruker Announces Agreement to Acquire Neurescence Inc. to Strengthen Neuroscience Research Portfolio
Bruker Corporation today announced that it has signed a definitive agreement to acquire 100% ownership of Neurescence Inc., an innovative provider of ultralight fiber bundle Multiscopes™ for simultaneous optical functional neuroimaging in multiple regions. Chromatone™, Neurescence's flagship product, removes lighting and detection hardware from the animal's head. This enables simultaneous imaging and stimulation of three subtypes of neurons in up to four regions for flexible study of the central nervous system at single-neuron resolution in naturalistic behavior. This platform creates strong synergies with Bruker's existing Ultima multiphoton solutions and the newly acquired Inscopix head-mounted miniscopes. Financial details of the agreement were not disclosed.
Our differentiated system provides a viable means of conducting studies in multiple regions of interest with minimal impact on animal weight. Now with Bruker we can significantly expand the global reach of this technology, enabling researchers to gain deeper knowledge of the functions of neural networks.”
Dr. Yasaman Soudagar, Co-founder and CEO, Neurescence
“Together with our recent acquisition of Inscopix, this acquisition strengthens Bruker's position as a leader in imaging and photostimulation for freely moving animals,” added Dr. Mark R. Munch, President of the Bruker NANO Group, added. “Neurescence’s extremely flexible and lightweight Multiscope™ fiber bundle with an animal-free approach has great potential to address diverse research needs and future trends and open the door to advanced imaging modalities.”
Source:
.